Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30,914	50,548	21,785	10,366	6,271	8,766
Market Cap Growth	-51.33%	132.03%	110.16%	65.31%	-28.46%	3.46%
Enterprise Value	14,733	41,733	20,319	10,519	5,364	7,371
Last Close Price	439.10	715.50	373.20	201.40	145.10	220.60
PE Ratio	4.69	-	-	-	-	-
PS Ratio	3.39	806.30	63.55	99.69	57.77	45.65
PB Ratio	1.98	5.87	13.68	12.71	6.76	7.13
P/TBV Ratio	1.98	5.88	13.78	12.71	7.17	7.48
P/FCF Ratio	4.11	-	-	-	-	-
P/OCF Ratio	4.10	-	-	-	-	-
EV/Sales Ratio	1.62	665.70	59.28	101.16	49.41	38.39
EV/FCF Ratio	1.96	-	-	-	-	-
Debt / Equity Ratio	0.03	0.05	0.08	0.64	0.85	0.11
Debt / FCF Ratio	0.05	-	-	-	-	-
Asset Turnover	0.67	0.01	0.20	0.06	0.06	0.11
Inventory Turnover	-	0.85	0.69	-	0.12	-
Quick Ratio	15.08	21.11	6.23	6.73	4.80	3.71
Current Ratio	15.09	21.14	6.25	6.73	5.15	4.00
Return on Equity (ROE)	53.44%	-21.13%	-58.43%	-110.75%	-69.99%	-54.10%
Return on Assets (ROA)	32.86%	-13.81%	-19.93%	-28.30%	-25.53%	-23.29%
Return on Capital (ROIC)	34.83%	-14.80%	-22.99%	-33.41%	-31.80%	-29.12%
Earnings Yield	21.61%	-2.13%	-3.23%	-11.60%	-16.24%	-9.66%
FCF Yield	24.35%	-1.86%	-2.01%	-9.20%	-19.68%	-8.14%
Buyback Yield / Dilution	-18.37%	-17.40%	-22.49%	-7.77%	-11.73%	-13.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.